3,0
9 jan 2024
Voormalige werknemer, meer dan 5 jaar
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht
Pluspunten
Big company without good drugs in the pipeline
Minpunten
Seems like a different company without Ken Fraiser. Culture is very clickish IT does things the Merck way Not great pay Layoffs attitude about being a big pharma, but no greatness Layoffs on the hush so they dont get bad press EIC plan in Austin - didnt come through for those employees